SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001453687-24-000076
Filing Date
2024-04-26
Accepted
2024-04-26 09:09:18
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A rnac-20240426.htm   iXBRL DEF 14A 1095068
3 rnac-20240426_g1.jpg GRAPHIC 9435
4 rnac-20240426_g2.jpg GRAPHIC 226351
5 rnac-20240426_g3.jpg GRAPHIC 465914
6 rnac-20240426_g4.jpg GRAPHIC 255964
  Complete submission text file 0001453687-24-000076.txt   3957456

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240426.xsd EX-101.SCH 950
18 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240426_htm.xml XML 137779
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37798 | Film No.: 24879126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)